Smith & Nephew (NYSE:SNN) Downgraded to Hold Rating by Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew (NYSE:SNN) from a buy rating to a hold rating in a report issued on Friday morning, Marketbeat.com reports.

Separately, StockNews.com raised Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Monday, August 5th. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Smith & Nephew Stock Performance

SNN traded up $0.15 during trading on Friday, hitting $25.24. 1,070,064 shares of the company’s stock were exchanged, compared to its average volume of 799,524. Smith & Nephew has a fifty-two week low of $23.24 and a fifty-two week high of $31.72. The business’s 50 day moving average is $29.98 and its two-hundred day moving average is $27.79. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51.

Hedge Funds Weigh In On Smith & Nephew

Several hedge funds have recently modified their holdings of the company. Mather Group LLC. lifted its holdings in Smith & Nephew by 9,735.3% during the second quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock worth $42,000 after acquiring an additional 1,655 shares during the period. Allspring Global Investments Holdings LLC grew its position in Smith & Nephew by 1,894.3% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider’s stock valued at $43,000 after buying an additional 1,648 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Smith & Nephew by 92.5% during the second quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock worth $61,000 after buying an additional 1,179 shares during the last quarter. GAMMA Investing LLC boosted its stake in Smith & Nephew by 160.0% in the third quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock valued at $70,000 after acquiring an additional 1,389 shares during the last quarter. Finally, Headlands Technologies LLC increased its stake in shares of Smith & Nephew by 225.0% during the 1st quarter. Headlands Technologies LLC now owns 3,851 shares of the medical equipment provider’s stock worth $98,000 after purchasing an additional 2,666 shares during the last quarter. Institutional investors own 25.64% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.